Ovarian Reserve Testing: AMH, AFC, and What Results Mean

Ovarian reserve testing uses blood tests and ultrasound to estimate how many eggs may remain in the ovaries and how the ovaries may respond to fertility treatment. Results are helpful for planning, but they do not predict pregnancy with certainty or define a person's overall fertility on their own.

Overview: What Is Ovarian Reserve Testing?

Ovarian reserve testing is a group of assessments used to estimate the remaining supply of eggs in the ovaries. The most common tests are the anti-Müllerian hormone test, known as AMH, and the antral follicle count, known as AFC. These results help fertility specialists understand how the ovaries may respond to medications used in in vitro fertilization, or IVF, and other fertility treatments.

It is important to understand what ovarian reserve testing can and cannot show. The tests give information about egg quantity, or the likely number of recruitable follicles, but they do not directly measure egg quality. Egg quality is strongly related to age, and it affects the chance that an egg will fertilize, develop normally, implant, and result in a healthy pregnancy.

Ovarian reserve results are not a simple pass-or-fail measure of fertility. A person with low AMH may still ovulate and become pregnant, while a person with high AMH may still need evaluation for ovulation problems, tubal factors, endometriosis, uterine conditions, or sperm-related factors. For this reason, results are most useful when interpreted as part of a complete fertility assessment.

AMH Test: What It Measures

Anti-Müllerian hormone is produced by cells surrounding small growing follicles in the ovaries. Because the number of these small follicles is related to the remaining pool of eggs, AMH is used as an indirect marker of ovarian reserve. It is measured with a blood test and can usually be checked on almost any day of the menstrual cycle.

AMH levels generally decline with age, although the pace of decline varies from person to person. A lower AMH result may suggest a smaller number of remaining recruitable follicles and a potentially lower response to ovarian stimulation. A higher AMH result may suggest a larger number of small follicles and, in some cases, may be associated with polycystic ovary syndrome, or PCOS.

AMH values can vary between laboratories and testing platforms, so the exact number should be interpreted using the reference range of the laboratory and the clinical context. Hormonal contraception, recent ovarian surgery, pregnancy, certain medical treatments, and individual biological variation may influence results. A fertility specialist may repeat a test or combine it with ultrasound if the result does not fit the clinical picture.

Antral Follicle Count: What the Ultrasound Shows

Antral follicle count is measured during a transvaginal ultrasound. The clinician counts the small fluid-filled follicles visible in both ovaries, usually early in the menstrual cycle, although many clinics can assess it at other times depending on the situation. These follicles are the group that may potentially respond to stimulation in that cycle.

AFC is useful because it gives a direct visual estimate of small follicles. It can also show other findings that may matter for fertility planning, such as ovarian cysts, endometriomas, or features suggestive of PCOS. The ultrasound can also assess the uterus and sometimes identify fibroids, polyps, or changes in the uterine lining that may need further evaluation.

Like AMH, antral follicle count is not an exact count of all remaining eggs. It is a practical clinical estimate and may vary slightly depending on the ultrasound machine, the timing of the scan, the experience of the examiner, and whether ovarian cysts or previous surgery make one ovary harder to visualize. When AMH and AFC are considered together, they often provide a clearer picture than either test alone.

What Results May Mean

Ovarian reserve results are usually described as low, expected for age, or high. These categories are not universal, because laboratories, clinics, and guidelines may use different cutoffs. A result should always be interpreted in relation to age, menstrual history, previous fertility outcomes, ultrasound findings, and the reason for testing.

A low AMH or low AFC may suggest diminished ovarian reserve. This means the ovaries may produce fewer eggs during IVF stimulation, and there may be less time to delay fertility plans. However, it does not mean that ovulation has stopped, and it does not rule out pregnancy. Some people with low reserve conceive naturally, while others may need individualized fertility treatment.

A high AMH or high AFC often suggests a strong ovarian response to stimulation. This may be reassuring in terms of expected egg numbers, but it can also mean that medication plans need to be carefully tailored to reduce the risk of ovarian hyperstimulation. High results may also prompt evaluation for PCOS if there are irregular periods, acne, increased facial or body hair, or other signs of hormonal imbalance.

Normal ovarian reserve results can be helpful, but they do not guarantee fertility. Tubal health, sperm quality, ovulation, uterine factors, lifestyle, medical conditions, and the timing of intercourse or treatment all affect the chance of pregnancy. Ovarian reserve testing is one part of the larger fertility picture.

Who May Benefit From Ovarian Reserve Testing?

Ovarian reserve testing is commonly offered to people who are trying to conceive and have not become pregnant after an appropriate period of time, especially if they are in their mid-30s or older. It may also be recommended earlier for people with irregular periods, known ovarian conditions, or a history that may affect ovarian function.

Testing may be particularly useful before IVF because it helps the medical team choose a stimulation protocol and counsel patients about expected egg yield. It may also support decisions about fertility preservation, such as egg or embryo freezing, especially before chemotherapy, radiotherapy, ovarian surgery, or other treatments that could affect the ovaries.

Common reasons for considering ovarian reserve testing include:

• Planning IVF or another fertility treatment
• Age-related fertility planning, especially after the mid-30s
• Previous poor response to ovarian stimulation
• Endometriosis or planned ovarian cyst surgery
• Previous chemotherapy, pelvic radiation, or ovarian surgery
• Family history of early menopause or premature ovarian insufficiency
• Considering egg freezing or embryo freezing

Causes and Risk Factors for Lower Ovarian Reserve

Age is the most common factor associated with declining ovarian reserve. People are born with a finite number of eggs, and the number decreases naturally over time. In addition, the proportion of eggs with chromosomal abnormalities increases with age, which is why age remains central to fertility counseling even when AMH or AFC results appear reassuring.

Some medical and lifestyle factors may be associated with lower ovarian reserve or earlier decline. These include previous ovarian surgery, particularly surgery for endometriomas; chemotherapy or radiation involving the pelvis; smoking; certain genetic conditions; autoimmune disorders; and a family history of early menopause. Severe endometriosis may also affect ovarian reserve, especially when it involves the ovaries.

Sometimes low ovarian reserve is found without a clear cause. This can feel unexpected, particularly for someone with regular periods. A careful review by a fertility specialist can help determine whether additional tests are needed, such as evaluation for premature ovarian insufficiency, thyroid disease, prolactin abnormalities, or genetic counseling in selected cases.

How Results Guide Fertility Treatment

In IVF, ovarian reserve testing helps guide medication choices and counseling. A person with lower reserve may need a treatment plan designed for a lower expected egg yield, while a person with high reserve may need a protocol that reduces the chance of excessive ovarian response. The goal is to make treatment as safe and individualized as possible.

For people not yet ready to conceive, results may inform timing and fertility preservation discussions. Egg freezing or embryo freezing may be considered, but the decision depends on age, ovarian reserve, relationship circumstances, medical history, values, and realistic expectations. Ovarian reserve tests can help estimate response to stimulation, but they cannot guarantee the future use or success of frozen eggs or embryos.

If ovarian reserve is very low, treatment options may still exist. These may include attempting conception naturally for a defined period, ovulation tracking when appropriate, IVF with individualized stimulation, or discussion of donor eggs in some cases. The best option depends on the whole clinical situation, including age, previous pregnancies, sperm results, tubal status, and personal preferences.

At specialized fertility centers, care often involves reproductive endocrinologists, embryologists, nurses, ultrasound specialists, and counselors working together. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals evaluate and treat fertility concerns, including ovarian reserve issues, for international patients seeking coordinated care.

When to See a Fertility Specialist

A person may consider seeing a fertility specialist if pregnancy has not occurred after 12 months of regular unprotected intercourse under age 35, or after 6 months at age 35 or older. Earlier evaluation is recommended for people with irregular or absent periods, known endometriosis, previous pelvic surgery, a history of chemotherapy or radiation, recurrent pregnancy loss, or suspected sperm-related concerns.

Medical advice is also useful when an ovarian reserve result is unexpectedly low or high. A specialist can explain whether the result is meaningful, whether it should be repeated, and what additional tests may be appropriate. This may include a pelvic ultrasound, hormone tests, ovulation assessment, tubal evaluation, semen analysis, or review of previous medical records.

Patients should avoid making major decisions based on a single number alone. Ovarian reserve testing is most helpful when it supports a clear plan that reflects the person’s age, goals, health status, and timeline. A qualified doctor can help translate the results into practical next steps without unnecessary worry.

Frequently asked questions

Does a low AMH mean pregnancy is impossible?

No. A low AMH suggests that the ovaries may have fewer recruitable follicles and may produce fewer eggs during IVF stimulation. It does not prove that ovulation has stopped or that pregnancy cannot happen. Age, egg quality, sperm factors, tubal health, and overall reproductive health also matter.

Can AMH predict natural fertility?

AMH is better at predicting ovarian response to fertility medications than predicting the chance of natural conception. Some people with low AMH conceive naturally, while some with normal AMH may have difficulty because of other fertility factors. A full fertility evaluation gives a more accurate picture.

What is the difference between AMH and AFC?

AMH is a blood test that reflects hormone production from small ovarian follicles. AFC is an ultrasound count of small visible follicles in both ovaries. They assess related aspects of ovarian reserve and are often interpreted together.

Can ovarian reserve be improved?

There is no proven treatment that restores the original number of eggs in the ovaries. However, general health measures such as avoiding smoking, maintaining a healthy lifestyle, and managing medical conditions may support reproductive health. Fertility specialists can individualize treatment plans to make the best use of the available ovarian response.

Does a high AMH mean better fertility?

A high AMH may mean there are many small follicles and a potentially strong response to IVF stimulation. It does not guarantee pregnancy, because egg quality, ovulation, sperm, tubes, and the uterus also play important roles. High AMH may sometimes be seen with PCOS, especially when periods are irregular.

When in the cycle should ovarian reserve testing be done?

AMH can usually be measured on most days of the menstrual cycle, although clinic practices may vary. AFC is commonly measured by ultrasound early in the menstrual cycle, when small follicles are easiest to count. A fertility clinic can advise the best timing based on the person's cycle and treatment plan.

Should someone test ovarian reserve before egg freezing?

Yes, ovarian reserve testing is commonly part of counseling before egg freezing. AMH and AFC help estimate how many eggs may be collected in a stimulation cycle, although they cannot guarantee future pregnancy. Age remains a key factor because it is closely related to egg quality.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.